Brands Browse Interactions Pill ID Categories

Loading…

Drugvu is an independent compilation of publicly-disclosed pharmaceutical regulatory information. It is not affiliated with the FDA, EMA, MHRA, Health Canada, TGA, TİTCK, PMDA, or any pharmaceutical manufacturer or regulatory agency.

This is not medical advice. Always consult a qualified healthcare professional for medical decisions.

About Editorial process Editorial team Data sources Methodology Corrections Contribute Privacy Terms DMCA Contact

Dabrafenib and Relugolix: Minor Interaction - Drugvu

🏠›Dabrafenib›Interaction with Relugolix

Dabrafenib + Relugolix

Drug interaction

Minor interaction

A minor drug-drug interaction between Dabrafenib and Relugolix is recorded in public interaction data. Severity reflects the source classification; it does not describe your individual risk. Do not start, stop, or change either medicine based on this page.

What “minor” means

A minor interaction is usually of limited importance for most people, though it is still worth being aware of.

What to do

Usually no change is needed - but ask your pharmacist if you notice anything unusual.

The two medicines

Active ingredient

Dabrafenib

B-Raf Serine-Threonine Kinase (Braf) Inhibitors

Uses, side effects, dosage →· 386 recorded interactions

Active ingredient

Relugolix

Other Hormone Antagonists and Related Agents

Uses, side effects, dosage →· 233 recorded interactions

Source

DDInter 2.0 (CC-BY 4.0, https://ddinter.scbdd.com)

This is not medical advice. Drugvu is an independent aggregator of public records.